Stay updated on Pembrolizumab for Mesothelioma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab for Mesothelioma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab for Mesothelioma Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    The page’s revision/version identifier updates from “Revision: v3.5.2” to “Revision: v3.5.3,” reflecting a change to the website’s software version without altering the study record information.
    Difference
    0.1%
    Check dated 2026-04-24T05:46:58.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    Added 'Results Submission Events (1)' and 'Revision: v3.5.2'; removed 'Revision: v3.5.0' from the history.
    Difference
    0.3%
    Check dated 2026-04-17T02:13:07.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    Addition of 'Results Submitted' and removal of 'No Results Posted' are reflected in the study record history.
    Difference
    0.1%
    Check dated 2026-04-02T15:15:55.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    Footer revision label updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-19T05:10:27.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    A new revision entry labeled v3.4.3 has been added to the Record History, and the previous v3.4.2 entry has been removed.
    Difference
    0.1%
    Check dated 2026-03-12T02:16:09.000Z thumbnail image
  8. Check
    90 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 to the record history. Removed the funding-lapse notice and Revision: v3.4.1 from the history.
    Difference
    0.8%
    Check dated 2026-02-11T12:08:22.000Z thumbnail image

Stay in the know with updates to Pembrolizumab for Mesothelioma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Mesothelioma Clinical Trial page.